147 related articles for article (PubMed ID: 12077596)
1. Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation.
Masood N; Russell KJ; Olerud JE; Sabath DE; Sale GE; Doney KC; Flowers ME; Fefer A; Thompson JA
J Am Acad Dermatol; 2002 Jul; 47(1):140-5. PubMed ID: 12077596
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation in mycosis fungoides.
Atalla A; Hallack Neto AE; Siqueira DB; Toledo GC
An Bras Dermatol; 2013; 88(6 Suppl 1):216-9. PubMed ID: 24346924
[TBL] [Abstract][Full Text] [Related]
4. Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation.
Frederiks AJ; Creeper KJ; Spagnolo DV; Cannell P; Radeski D
Australas J Dermatol; 2021 Aug; 62(3):e400-e403. PubMed ID: 34028795
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect.
Burt RK; Guitart J; Traynor A; Link C; Rosen S; Pandolfino T; Kuzel TM
Bone Marrow Transplant; 2000 Jan; 25(1):111-3. PubMed ID: 10654025
[TBL] [Abstract][Full Text] [Related]
6. Dramatic response to brentuximab vedotin in refractory nontransformed CD30
Mahévas T; Ram-Wolff C; Battistella M; Pennamen MDV; Rivet J; Brice P; Bagot M
Br J Dermatol; 2019 Jun; 180(6):1517-1520. PubMed ID: 30269331
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
[TBL] [Abstract][Full Text] [Related]
8. Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Novelli S; Martín A; Sánchez JJ; Espeso M; Mozos A; Briones J
Eur J Dermatol; 2020 Aug; 30(4):397-403. PubMed ID: 32815814
[TBL] [Abstract][Full Text] [Related]
9. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
[TBL] [Abstract][Full Text] [Related]
11. Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma.
Guitart J; Wickless SC; Oyama Y; Kuzel TM; Rosen ST; Traynor A; Burt R
Arch Dermatol; 2002 Oct; 138(10):1359-65. PubMed ID: 12374543
[TBL] [Abstract][Full Text] [Related]
12. Successful cord blood transplantation for mycosis fungoides.
Fukushima T; Horio K; Matsuo E; Imanishi D; Yamasaki R; Tsushima H; Imaizumi Y; Ohshima K; Hata T; Yoshida S; Miyazaki Y; Tomonaga M
Int J Hematol; 2008 Dec; 88(5):596-598. PubMed ID: 18998050
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
Goyal A; Foss F
Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.
Wu PA; Kim YH; Lavori PW; Hoppe RT; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 2009 Aug; 15(8):982-90. PubMed ID: 19589488
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Domingo-Domenech E; Duarte RF; Boumedil A; Onida F; Gabriel I; Finel H; Arcese W; Browne P; Beelen D; Kobbe G; Veelken H; Arranz R; Greinix H; Lenhoff S; Poiré X; Ribera JM; Thompson J; Zuckerman T; Mufti GJ; Cortelezzi A; Olavarria E; Dreger P; Sureda A; Montoto S
Bone Marrow Transplant; 2021 Jun; 56(6):1391-1401. PubMed ID: 33420392
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).
Atilla E; Atilla PA; Bozdag SC; Yuksel MK; Toprak SK; Topcuoglu P; Akay BN; Sanli H; Gurman G; Ozcan M
Int J Hematol; 2017 Sep; 106(3):426-430. PubMed ID: 28466385
[TBL] [Abstract][Full Text] [Related]
17. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.
Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H
Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.
Goyal A; O'Leary D; Foss F
Bone Marrow Transplant; 2024 Jan; 59(1):41-51. PubMed ID: 37853164
[TBL] [Abstract][Full Text] [Related]
19. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
20. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Duvic M; Donato M; Dabaja B; Richmond H; Singh L; Wei W; Acholonu S; Khouri I; Champlin R; Hosing C
J Clin Oncol; 2010 May; 28(14):2365-72. PubMed ID: 20351328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
